Cargando…
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines
One of the main obstacles to the effective treatment of ovarian cancer patients continues to be the drug resistance of cancer cells. Osteoblast-Specific Factor 2 (OSF-2, Periostin) is a secreted extracellular matrix protein (ECM) expressed in fibroblasts during bone and teeth development. Expression...
Autores principales: | Sterzyńska, Karolina, Kaźmierczak, Dominika, Klejewski, Andrzej, Świerczewska, Monika, Wojtowicz, Karolina, Nowacka, Marta, Brązert, Jacek, Nowicki, Michał, Januchowski, Radosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719218/ https://www.ncbi.nlm.nih.gov/pubmed/31412536 http://dx.doi.org/10.3390/ijms20163927 |
Ejemplares similares
-
Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines
por: Sterzyńska, Karolina, et al.
Publicado: (2018) -
Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development
por: Sterzyńska, Karolina, et al.
Publicado: (2018) -
The significance of lumican expression in ovarian cancer drug-resistant cell lines
por: Klejewski, Andrzej, et al.
Publicado: (2017) -
The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
por: Sterzyńska, Karolina, et al.
Publicado: (2018) -
New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
por: Świerczewska, Monika, et al.
Publicado: (2017)